UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
| x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Quarterly Period Ended December 31, 2004
| ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the Transition Period from:
Commission File Number 0-21422
OPTi Inc.
(exact name of registrant as specified in this charter)
| California | 77-0220697 | |
| (State or other jurisdiction of incorporated or organization) |
(I.R.S. Employer Identification No.) | |
| 880 Maude Avenue, Suite A, Mountain View, CA | 94043 | |
| (Address of principal executive offices) | (Zip Code) | |
Registrants telephone number, including area code (650) 625-8787
Indicate by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the proceeding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filings requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES ¨ NO x
The number of shares outstanding of the registrants common stock as of January 31, 2005 was 11,633,903.
Form 10-Q
For the Quarterly Period Ended December 31, 2004
INDEX
| Page | ||||
| Part I. Financial Information |
||||
| Item 1. Financial Statements (Unaudited) |
||||
| 3 | ||||
| b) Condensed Consolidated Balance Sheets as of December 31, 2004 and March 31, 2004 |
4 | |||
| 5 | ||||
| 6 | ||||
| Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations |
10 | |||
| Item 3. Quantitative and Qualitative Disclosure about Market Risks |
13 | |||
| Item 4. Controls and Procedures |
14 | |||
| Part II. Other information |
||||
| Item 1. Legal Proceedings |
15 | |||
| Item 2. Unregistered Sales of Equity Securities and Use of Proceeds |
15 | |||
| Item 3. Defaults Upon Senior Securities |
15 | |||
| 15 | ||||
| Item 5. Other Information |
15 | |||
| Item 6. Exhibits |
15 | |||
| 16 | ||||
2
Part I. Financial Information
Item 1. Financial Statements (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(000s omitted, except per share data)
| Three Months Ended December 31, |
Nine Months Ended December 31, | ||||||||||||||
| 2004 |
2003 |
2004 |
2003 | ||||||||||||
| Revenue |
|||||||||||||||
| License and royalties |
$ | | $ | 171 | $ | 52 | $ | 907 | |||||||
| Net Sales |
| 171 | 52 | 907 | |||||||||||
| Costs and expenses |
|||||||||||||||
| Selling, general and administrative |
447 | 273 | 1,132 | 762 | |||||||||||
| Total costs and expenses |
447 | 273 | 1,132 | 762 | |||||||||||
| Operating income (loss) |
(447 | ) | (102 | ) | (1,080 | ) | 145 | ||||||||
| Interest and other income, net |
63 | 337 | 134 | 404 | |||||||||||
| Income (loss) before income tax provision (benefit) |
(384 | ) | 235 | (946 | ) | 549 | |||||||||
| Income tax benefit |
| | 75 | | |||||||||||
| Net income (loss) |
$ | (384 | ) | $ | 235 | $ | (871 | ) | $ | 549 | |||||
| Basic net income (loss) per share |
$ | (0.03 | ) | $ | 0.02 | $ | (0.07 | ) | $ | 0.05 | |||||
| Diluted net income (loss) per share |
$ | (0.03 | ) | $ | 0.02 | $ | (0.07 | ) | $ | 0.05 | |||||
| Shares used in computing basic per share amounts |
11,634 | 11,634 | 11,634 | 11,634 | |||||||||||
| Shares used in computing diluted per share amounts |
11,634 | 11,634 | 11,634 | 11,634 | |||||||||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
CONDENSED CONSOLIDATED BALANCE SHEETS
(000s omitted)
| December 31, 2004 |
March 31, 2004 * | ||||||
| Unaudited | |||||||
| Assets |
|||||||
| Current assets |
|||||||
| Cash and cash equivalents |
$ | 14,839 | $ | 15,520 | |||
| Accounts receivable |
| 143 | |||||
| Other current assets |
61 | 58 | |||||
| Total current assets |
14,900 | 15,721 | |||||
| Property and equipment, net |
12 | 9 | |||||
| Other assets |
| 14 | |||||
| Total assets |
$ | 14,912 | $ | 15,744 | |||
| Liabilities and Shareholders Equity |
|||||||
| Current Liabilities |
|||||||
| Accounts payable |
$ | 73 | $ | 26 | |||
| Accrued expenses |
234 | 164 | |||||
| Income taxes payable |
1 | 78 | |||||
| Accrued employee expenses |
1 | 2 | |||||
| Total current liabilities |
309 | 270 | |||||
| Commitments and contingencies |
|||||||
| Shareholders equity |
|||||||
| Preferred stock, no par value |
|||||||
| Authorized shares - 5,000 |
|||||||
| No shares issued or outstanding |
| | |||||
| Common stock, no par value |
|||||||
| Authorized shares - 50,000 |
|||||||
| Issued and outstanding - 11,634 at December 31, and March 31, 2004 |
15,053 | 15,053 | |||||
| Retained earnings |
(450 | ) | 421 | ||||
| Total Shareholders Equity |
14,603 | 15,474 | |||||
| Total Liabilities and Shareholders Equity |
$ | 14,912 | $ | 15,744 | |||
| * | The balance sheet of March 31, 2004 has been derived from the audited financial statements at that date. |
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
| Nine Months Ended December 31 |
||||||||
| 2004 |
2003 |
|||||||
| (000s omitted) | ||||||||
| Operating Activities: |
||||||||
| Net income (loss) |
$ | (871 | ) | $ | 549 | |||
| Adjustments: |
||||||||
| Depreciation |
3 | 3 | ||||||
| Gain on Tripath Technology distribution |
| (306 | ) | |||||
| Changes in assets and liabilities: |
||||||||
| Accounts receivable |
143 | 97 | ||||||
| Other assets |
11 | 10 | ||||||
| Accounts payable |
47 | (45 | ) | |||||
| Accrued expenses |
(7 | ) | (9 | ) | ||||
| Accrued employee expenses |
(1 | ) | (3 | ) | ||||
| Net cash provided by (used in) operating activities |
(675 | ) | 296 | |||||
| Investing Activities: |
||||||||
| Proceeds from sell of Tripath Technologies, Inc. stock |
| 315 | ||||||
| Purchase of equipment |
(6 | ) | (9 | ) | ||||
| Net cash provided by (used in) investing activities |
(6 | ) | 306 | |||||
| Financing Activities: |
||||||||
| Net cash provided by financing activities |
| | ||||||
| Net increase (decrease) in cash and cash equivalents |
(681 | ) | 602 | |||||
| Cash and cash equivalents beginning of period |
15,520 | 14,996 | ||||||
| Cash and cash equivalents end of period |
$ | 14,839 | $ | 15,598 | ||||
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2004
(Unaudited)
1. Basis of Presentation
The information at December 31, 2004 and for the three and nine-month periods ended December 31, 2004 and 2003, are unaudited, but include all adjustments (consisting of normal recurring accruals) which the Companys management believes to be necessary for the fair presentation of the financial position, results of operations and cash flows for the periods presented. Interim results are not necessarily indicative of results for a full year.
The accompanying financial statements should be read in conjunction with the Companys audited financial statements for the year ended March 31, 2004.
Sale of the Product Fabrication, Distribution and Sales Operations
OPTi was founded in 1989 and was an independent supplier of semiconductor products to the personal computer market. On September 30, 2002, the Company announced that it had sold its product fabrication, distribution and sales operations to Opti Technologies, Inc., an unrelated third party. As part of the transaction Opti Technologies paid the Company $275,000 in licensing fees and acquired the existing inventory at cost. The Company was also entitled to quarterly royalty payments for the sale of its core logic and USB products. The Company received license and royalty payments in the aggregate amount of $1,500,000. The final payment was received in the quarter ended September 30, 2004. No additional payments are expected from Opti Technologies related to this transaction.
Currently, the Company is pursuing revenue through the pursuit of licenses from users of its intellectual property. The Company does not expect to receive additional significant revenue other than any that may result through the pursuit of its patent infringement cases and associated licensee efforts.
Use of Estimates
The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Stock-based compensation
The Company accounts for stock-based compensation arrangements in accordance with the provisions of APB No. 25 (APB No. 25), Accounting for Stock Issued to Employees and complies with the provisions of Statement of Financial Accounting Standard No. 123 (SFAS No. 123), Accounting for Stock-Based Compensation. Under APB No. 25, compensation cost is, in general, recognized based on the excess, if any, of the fair market value of the Companys stock on the date of grant over the exercise price an employee must pay to acquire the stock. Equity instruments issued to non-employees are accounted for in accordance with the provisions of SFAS No. 123 and Emerging Issues Task Force 96-18.
SFAS No. 123 pro forma disclosures
Had compensation cost for the Companys option plans been determined using the fair value at the grant dates, as prescribed in SFAS No. 123, the Companys net income (loss) would have been as follows (in thousands, except per share amounts):
| Three-Months Ended December 31, |
Nine-Months Ended December 31, | |||||||||||||
| 2004 |
2003 |
2004 |
2003 | |||||||||||
| Net income (loss): |
||||||||||||||
| As reported |
$ | (384 | ) | $ | 235 | $ | (871 | ) | $ | 549 | ||||
| Less: Total stock-based employee compensation expense under the fair value based methods for all awards, net of related tax effects |
1 | 3 | 3 | 3 | ||||||||||
| Pro forma net income (loss) |
$ | (385 | ) | $ | 232 | $ | (874 | ) | $ | 546 | ||||
| Pro forma basic net income (loss) per share |
$ | (0.03 | ) | $ | 0.02 | $ | (0.07 | ) | $ | 0.05 | ||||
| Pro forma diluted net income (loss) per share |
$ | (0.03 | ) | $ | 0.02 | $ | (0.07 | ) | $ | 0.05 | ||||
6
2. Net Income (Loss) Per Share
Basic net income (loss) per share and diluted net loss per share is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income per share is calculated using the weighted average number of common and dilutive common equivalent shares outstanding during the period. Common equivalents shares consist of stock options. At December 31, 2004 and 2003, options for 150,666 shares at exercise prices ranging from $1.27 to $7.50 were outstanding and were excluded from the earnings (loss) per share calculator as there effects would have been antidilutive.
The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share amounts):
| Three Months ended December 31, |
Nine-Months ended December 31, | |||||||||||||
| 2004 |
2003 |
2004 |
2003 | |||||||||||
| Net income (loss) |
$ | (384 | ) | $ | 235 | $ | (871 | ) | $ | 549 | ||||
| Weighted average number of common shares outstanding |
11,634 | 11,634 | 11,634 | 11,634 | ||||||||||
| Basic net income (loss) per share |
$ | (0.03 | ) | $ | 0.02 | $ | (0.08 | ) | $ | 0.05 | ||||